Medspa operators are reporting a surge in demand for Botox and filler treatments bundled into "Ozempic face" facials—preventive and corrective protocols designed to address the facial changes associated with rapid weight loss from GLP-1 agonists. The trend combines neuromodulator injections, volumizing fillers, and non-invasive skin-tightening modalities (RF microneedling, ultrasound) into a single treatment package.
Market
"Ozempic Face" Facials Driving Botox Boom as GLP-1 Users Seek Preventive Aesthetics
Medspa demand for neuromodulators and skin-tightening treatments accelerates as GLP-1 patients proactively address volume loss.
